[Solved] Drug Repurposing in COVID-19
The aim of this review is to describe regulatory and pharmacological aspects of drug repurposing and to identify drugs proposed for repurposing in COVID-19 based on the evidence to support their use in the treatment of this disease.The challenges of the correct interpretation of existing pre-clinical/clinical evidence as well as the generation of new evidence concerning drug repurposing in COVID-19 will also be discussed.
So much stress and so little time? We’ve got you covered. Get your paper proofread, edited or written from scratch within the tight deadline.
With us, you are either satisfied 100% or you get your money back-No monkey business